Results 1 to 10 of about 6,659 (189)

Optimizing Gene Therapies for Creatine Transporter Deficiency: Correcting by Connecting. [PDF]

open access: yesEpilepsy Curr
Connectomic and Behavioural Alterations in Creatine Transporter Deficiency are Partially Normalized by Gene Therapy Montani C, Iovino L, Di Vetta F, Rene’ Pasquin Mariani J-C, De Guzman AE, Gini S, Galbusera A, D ...
Lillis KP.
europepmc   +3 more sources

New Insights into Drug Development via the Nose-to-Brain Pathway: Exemplification Through Dodecyl Creatine Ester for Neuronal Disorders

open access: yesPharmaceutics
Brain disorders remain a major global health challenge, highlighting the urgent need for innovative therapeutic strategies and efficient drug-delivery approaches.
Henri Benech   +4 more
doaj   +1 more source

Genetic Determinants of Creatine Bioavailability and Responsiveness: Emphasis on Common Low-Impact Variants

open access: yesLifestyle Genomics
Background: Creatine is a central regulator of cellular energy homeostasis and one of the most extensively studied dietary supplements in human nutrition.
Sergej M. Ostojic, Ivana Kavecan
doaj   +1 more source

Intranasal CBT101 demonstrates favorable safety and neurophysiological evidence of central activity in healthy male volunteers

open access: yesFrontiers in Neurology
ObjectivesCBT101 is a creatine prodrug under development for disorders driven by impaired neuronal energy homeostasis, with initial development focused on creatine transporter deficiency and amyotrophic lateral sclerosis.
Henri Benech   +9 more
doaj   +1 more source

[18F]FDG-PET and [18F]MPPF-PET are brain biomarkers for the creatine transporter Slc6a8 loss of function mutation

open access: yesScientific Reports
Pathogenic variants in the creatine transporter gene SLC6A8, reported to represent 2% of all intellectual disabilities in males, result in a spectrum of behavioral abnormalities including developmental delay, intellectual disability, and deficit in ...
Isabel Day   +8 more
doaj   +1 more source

The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development. [PDF]

open access: yesGenes (Basel), 2021
Ghirardini E   +8 more
europepmc   +1 more source

X-linked creatine transporter deficiency results in prolonged QTc and increased sudden death risk in humans and disease model. [PDF]

open access: yesGenet Med, 2021
Levin MD   +18 more
europepmc   +1 more source

Connectomic and behavioural alterations in creatine transporter deficiency are partially normalized by gene therapy. [PDF]

open access: yesBrain
Montani C   +17 more
europepmc   +1 more source

Longitudinal Characterization of Males With X-Linked Creatine Transporter Deficiency: Final Results of a Multiyear Observational Study. [PDF]

open access: yesPediatr Neurol
Miller JS   +45 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy